Risk factors for coronary heart disease and survival after myocardial infarction

European Journal of Preventive Cardiology

Volumn 21, Issue 5, 2014, Pages 576-583

  Nauta, Sjoerd T ^a   Deckers, Jaap W ^a   Van Der Boon, Robert M ^a   Akkerhuis, K Martijn ^a   Van Domburg, Ron T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

coronary heart disease; diabetes; hyperlipidaemia; hypertension; long term survival; Mortality; NSTEMI; paradox; smoking; STEMI

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; TREND STUDY; AGED; COMORBIDITY; CORONARY CARE UNIT; CORONARY DISEASE; EPIDEMIOLOGY; HOSPITALIZATION; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NETHERLANDS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURVIVAL RATE; TIME;

AGED; COMORBIDITY; CORONARY CARE UNITS; CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SURVIVAL RATE; TIME FACTORS;

EID: 84900455583     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487312460514     Document Type: Article

References (15)

1. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 ; 14 (Suppl. 2). E1 - E40
2. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 ; 97: 1837-1847
3. Canto JG, Kiefe CI, Rogers WJ, et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011 ; 306: 2120-2127
4. Roe MT, Halabi AR, Mehta RH, et al. Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction. Am Heart J. 2007 ; 153: 507-514
5. Nauta ST, Deckers JW, Akkerhuis KM, et al. Age-dependent care and long-term (20year) mortality of 14,434 myocardial infarction patients: Changes from 1985 to 2008. Int J Cardiol 2012. Epub ahead of print March 2012. DOI: 10.1016/j.ijcard.2012.03.064.
6. Simoons ML, Serruys PW, vd Brand M, et al. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985 ; 2: 578-582
7. Nauta ST, Deckers JW, Akkerhuis M, et al. Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008. PLoS One. 2011 ; 6: e26917 - e26917
8. Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011 ; 305: 1677-1684
9. Lazzeri C, Valente S, Chiostri M, et al. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes. Eur J Cardiovasc Prev Rehabil. 2010 ; 17: 419-423
10. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004 ; 364: 937-952
11. Yang ZJ, Liu J, Ge JP, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: The 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J. 2012 ; 33: 213-220
12. Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011 ; 305: 822-823
13. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med. 2007 ; 356: 2388-2398
14. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000 ; 284: 835-842
15. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000 ; 101: 2557-2567